 Fate Therapeutics was one of my favorite investments, however, I made the haunting mistake of closing the position only to see the ticker nearly triple. This time will be different. FATE has lost roughly 60 over the past twelve months. I believe the ticker is trading near a reasonable valuation for its upside potential. I reveal my strategy. 